Access to Investigational Therapies
Avalo Therapeutics’ goal is to provide potentially life-saving therapies to patients who may benefit from them, while minimizing potential risk. Avalo believes that clinical trials are the most effective way for patients to access investigational products, as clinical trials can generate data that may lead to the approval of new medicines and wider availability to patients.
Clinical Study Information
To participate in a clinical study, you must meet certain eligibility criteria. These criteria identify similar disease characteristics which can allow researchers to better evaluate the investigational therapy. You should discuss participation in a clinical study with your physician who knows your medical history and current status and can help to determine whether you may be able to join a clinical study.
- Visit clinicaltrials.gov and search registered clinical studies for the disease.
- If you locate a clinical study with a participating site that you are interested in, you or your physician may contact that site directly for more information.
- For information about the ongoing Avalo Therapeutics Phase 2 LOTUS clinical trial to evaluate the efficacy and safety of AVTX-009 in moderate to severe hidradenitis suppurativa, please visit www.clinicaltrials.gov (NCT06603077).